Qurient

Developing novel small molecule therapeutics against infectious disease and inflammation

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2008 groups31 employees language qurient.com

Innovation

18 patent families (12 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 576 times.

YearFilings
20153
20165
20174
20184
20197
20206
20218
20229
202310
202410
20259
20262

Social engagement

Social engagement: 548 social following, 8 posts in the last 12 months — top 10% of its industry.

Investor mix

10 investors on record.

Investor typeCountShare
Venture capital770%
Private equity110%
Bank & private debt110%
Other / undisclosed110%

Recent activity

4 May 2026
Event
World ADC Korea 2026
14 Oct 2025
Event
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2025
14 Oct 2025
Event
Poster Session A in Exhibit Hall D
Coming soon